| ZyVersa Therapeutics, Inc. (ZVSA) |
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 |
| Balance Sheet Date | | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Period | | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Common Stock | | 0.30$ | 0.68$ | 0.61$ | 1.13$ | 2.41$ | 3.56$ | 0.75$ | 0.90$ | 0.13$ | 0.25$ | 1.93$ | 1.40$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Market Cap of Common Stock | | 1,414,375$ | 3,236,403$ | 1,574,301$ | 2,648,936$ | 2,480,362$ | 2,972,230$ | 5,696,907$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | | (56.30%) | 105.58% | (40.57%) | 6.80% | (16.55%) | (47.83%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | | (42.98%) | 8.89% | (72.37%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Warrant | | | | | | | | | | | | | 0.11$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Unit | | | | | | | | | | | | | 20.80$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Right | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Shares Outstanding | 8,095,921 | 8,095,921 | 4,873,456 | 2,568,191 | 2,508,191 | 1,074,196 | 834,896 | 834,896 | 402,205 | 124,336 | 67,626 | 26,319 | 257,604 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | .00% | 66.12% | 89.76% | 2.39% | 133.50% | 28.66% | .00% | 107.58% | 223.48% | 83.86% | 156.95% | (89.78%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | 222.78% | 653.67% | 483.72% | 207.61% | 523.61% | 763.95% | 1,134.58% | 3,072.22% | 56.13% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |